Eureka Bio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Eureka Bio General Information

Description

Developer of automated biotechnology platforms designed to address viral vector production challenges. The company's technology utilizes stable producer cell lines, serum-free suspension systems, closed automated tubing, centrifugal units, and continuous-flow processing, providing cell and gene therapy organizations with lentiviral vector production systems, automated cell processing equipment, and manufacturing solutions to reduce costs and enhance efficiency.

Contact Information

Formerly Known As
Shenzhen Gangke Shenyan Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 801, Block A, Garden City Digital Building, Number 1079 Nanhai Avenue
  • Yanshan Community, Zhaoshang Street, Nanshan District
  • Shenzhen, Guangdong 518023
  • China
+86 0755
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 801, Block A, Garden City Digital Building, Number 1079 Nanhai Avenue
  • Yanshan Community, Zhaoshang Street, Nanshan District
  • Shenzhen, Guangdong 518023
  • China
+86 0755

Eureka Bio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eureka Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 13-Jul-2026 Completed Generating Revenue
5. Later Stage VC (Series B1) 02-Feb-2024 Completed Generating Revenue
4. Later Stage VC (Series B) 09-Jun-2022 Completed Generating Revenue
3. Later Stage VC (Series A) 23-Apr-2021 Completed Generating Revenue
2. Later Stage VC 12-Oct-2020 Completed Generating Revenue
1. Corporate 03-Mar-2017 Completed Generating Revenue
To view Eureka Bio’s complete valuation and funding history, request access »

Eureka Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eureka Bio Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABC Capital Venture Capital Minority
Fortune Capital Venture Capital Minority
Guangdong Technology Financial Group Government Minority
Guangzhou Yuexiu Industrial Investment Fund Management PE/Buyout Minority
Guli High-end Equipment Accelerator/Incubator Minority
You’re viewing 5 of 14 investors. Get the full list »

Eureka Bio FAQs

  • When was Eureka Bio founded?

    Eureka Bio was founded in 2014.

  • Where is Eureka Bio headquartered?

    Eureka Bio is headquartered in Shenzhen, China.

  • What is the size of Eureka Bio?

    Eureka Bio has 35 total employees.

  • What industry is Eureka Bio in?

    Eureka Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Eureka Bio a private or public company?

    Eureka Bio is a Private company.

  • What is Eureka Bio’s current revenue?

    The current revenue for Eureka Bio is .

  • How much funding has Eureka Bio raised over time?

    Eureka Bio has raised $57M.

  • Who are Eureka Bio’s investors?

    ABC Capital, Fortune Capital, Guangdong Technology Financial Group, Guangzhou Yuexiu Industrial Investment Fund Management, and Guli High-end Equipment are 5 of 14 investors who have invested in Eureka Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process